Literature DB >> 18617363

Intermediate results of simultaneous alumina-on-alumina bearing and alumina-on-highly cross-linked polyethylene bearing total hip arthroplasties.

Young-Hoo Kim1, Jun-Shik Kim, Yoo-Wang Choi, Oh-Ryong Kwon.   

Abstract

This study compared the clinical and radiographic results and the prevalence of osteolysis between alumina-on-alumina and alumina-on-highly cross-linked polyethylene bearings after cementless total hip arthroplasties in the 100 patients younger than 50 years of age. There were 66 men and 34 women; the mean age at the time of surgery was 45.3 years (range, 25 to 49 years). The mean duration of follow-up was 5.6 years (range, five to seven years). The pre-and postoperative Harris hip scores were similar (39 and 41 points, respectively and 93 points and 94 points, respectively). No acetabular or femoral component had aseptic loosening in either group. The mean annual penetration of the highly cross-linked polyethylene was 0.06 +/- 0.03 mm. No hip in either group had acetabular or femoral osteolysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617363     DOI: 10.1016/j.arth.2008.05.009

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Comparative effectiveness of ceramic-on-ceramic implants in stemmed hip replacement: a multinational study of six national and regional registries.

Authors:  Art Sedrakyan; Stephen Graves; Barbara Bordini; Miquel Pons; Leif Havelin; Susan Mehle; Elizabeth Paxton; Thomas Barber; Guy Cafri
Journal:  J Bone Joint Surg Am       Date:  2014-12-17       Impact factor: 5.284

2.  Wear of a 5 megarad cross-linked polyethylene liner: a 6-year RSA study.

Authors:  Stuart A Callary; David G Campbell; Graham Mercer; Kjell G Nilsson; John R Field
Journal:  Clin Orthop Relat Res       Date:  2013-01-19       Impact factor: 4.176

Review 3.  History and systematic review of wear and osteolysis outcomes for first-generation highly crosslinked polyethylene.

Authors:  Steven M Kurtz; Heather A Gawel; Jasmine D Patel
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

4.  Early reactive synovitis and osteolysis after total hip arthroplasty.

Authors:  H John Cooper; Amar S Ranawat; Hollis G Potter; Li Foong Foo; Trevor W Koob; Chitranjan S Ranawat
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

5.  Cementless total hip arthroplasty with ceramic-on-ceramic bearing in patients younger than 45 years with femoral-head osteonecrosis.

Authors:  Young-Hoo Kim; Yoowang Choi; Jun-Shik Kim
Journal:  Int Orthop       Date:  2009-09-26       Impact factor: 3.075

6.  Alumina-on-Polyethylene Bearing Surfaces in Total Hip Arthroplasty.

Authors:  Yup Lee Jung; Shin-Yoon Kim
Journal:  Open Orthop J       Date:  2010-02-11

7.  A randomised prospective evaluation of ceramic-on-ceramic and ceramic-on-highly cross-linked polyethylene bearings in the same patients with primary cementless total hip arthroplasty.

Authors:  Young-Hoo Kim; Jang-Won Park; Sourabh S Kulkarni; Yoon-Hong Kim
Journal:  Int Orthop       Date:  2013-08-03       Impact factor: 3.075

8.  Gender Differences in Wear Rates for 28- vs 32-mm Ceramic Femoral Heads on Modern Highly Cross-linked Polyethylene at Midterm Follow-Up in Young Patients Undergoing Total Hip Arthroplasty.

Authors:  Jeffrey B Stambough; Gail Pashos; Ningying Wu; Jacob A Haynes; John M Martell; John C Clohisy
Journal:  J Arthroplasty       Date:  2015-10-28       Impact factor: 4.757

Review 9.  Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidence.

Authors:  Art Sedrakyan; Sharon-Lise T Normand; Stefan Dabic; Samantha Jacobs; Stephen Graves; Danica Marinac-Dabic
Journal:  BMJ       Date:  2011-11-29

10.  Eighteen-Year Results of Cementless THA with Alumina-on-HXLPE Bearings in Patients <30 Years Old: A Concise Follow-up of a Previous Report.

Authors:  Young-Hoo Kim; Jang-Won Park
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.